Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2003
08/07/2003US20030149056 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/07/2003US20030149052 Side effect reduction
08/07/2003US20030149050 Inhibitors of inflammation and reperfusion injury and methods of use thereof
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149046 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149041 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney
08/07/2003US20030149040 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
08/07/2003US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient
08/07/2003US20030149035 For therapy and prophylaxis of infections by herpesviruses
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149028 Pesticidal compositions
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149024 For therapy of central nervous system disorders such as diseases and conditions related to sleeping, eating, perceiving pain, controlling body temperature, controlling blood pressure, depression, anxiety, schizophrenia
08/07/2003US20030149023 Novel compounds with analgesic effect
08/07/2003US20030149022 Inhibiting beta -amyloid peptide release and/or its synthesis in a cell by administering deoxyamino acid compound
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149017 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
08/07/2003US20030145394 Helium-neon excitable reticulocyte dyes derivable from halolepidines
08/07/2003CA2474594A1 Delta1-pyrrolines
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473158A1 Treatment of rheumatoid arthritis using imatinib
08/07/2003CA2472342A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003CA2472103A1 Transmucosal delivery of proton pump inhibitors
08/07/2003CA2466915A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/06/2003EP1333025A1 Cyanopyrrolidine derivatives
08/06/2003EP1332196A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
08/06/2003EP1332141A1 Quinazoline derivatives
08/06/2003EP1332137A2 Treatment of gastrointestinal stromal tumors
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332135A1 Tagging compounds and process for use in aida libraries
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332129A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1126846B1 Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment of obsessive compulsive disorder
08/06/2003EP1049537B1 Catalytic compositions and methods for asymmetric allylic alkylation
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003EP0799209B1 Sulfonamides
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors
08/06/2003CN1434816A Novel compounds
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117089C Substituted 2(2,6-dioxopiperidin-3-yl)phthaliomides and -1-xoisoindolines and method of reducing TNF-alpha levels
08/06/2003CN1117086C Biphenyl-substituted triazines as light stabilizer
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas
08/06/2003CN1117080C Method for producing (hetero) aromatic hydroxylamines
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1116899C Oral pharmaceutical dosage forms comprising a proton pump inhibitorand NSAID
08/05/2003US6603009 Oxidation of a thioether to a sulfoxide using sodium percarbonate and a molybdenum salt as catalyst; making lansoprazole, omeprazole, rabeprazole, and pantoprazole
08/05/2003US6603006 Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use
08/05/2003US6603005 Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
08/05/2003US6602895 Inhibitors of factor Xa with a neutral P1 specificity group
08/05/2003US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
08/05/2003US6602889 5-heteroaryl substituted indoles
08/05/2003US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia
08/05/2003US6602886 3-alkyl-3-phenyl-piperidines
08/05/2003US6602885 Viricides, organ transplants, antiarthritic agents
08/05/2003US6602884 Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
08/05/2003US6602883 Inhibitors of farnesyl protein transferase
08/05/2003US6602882 Quinoline derivatives and their use as antibacterial agents
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
08/05/2003CA2113349C Method of producing a quinolonecarboxylic acid derivative
08/05/2003CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/05/2003CA2079373C (azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
07/2003
07/31/2003WO2003062280A2 Water-soluble dithioesters and method for polymerization thereof
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062227A1 Rho-kinase inhibitors
07/31/2003WO2003062226A1 Quinazoline(di) ones for invertebrate pest control
07/31/2003WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003WO2003062224A1 Aza-cyclic compounds as modulators of acetylcholine receptors
07/31/2003WO2003062223A1 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides
07/31/2003WO2003062222A1 Pyrazolecarboxamides, intermediates thereof and pesticides containing the same as the active ingredient
07/31/2003WO2003062221A1 Diamide invertebrate pest control agents
07/31/2003WO2003062220A1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003062206A2 Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
07/31/2003WO2003062205A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
07/31/2003WO2003062201A1 1,4-dihydropyridine and pyridine compounds as calcium channel blockers
07/31/2003WO2003061804A1 Purification of impure materials using non-aqueous solvents
1 ... 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 ... 1080